Search results
Results From The WOW.Com Content Network
Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, investor, medical researcher, and transplant surgeon. He is the inventor of the drug Abraxane, which is used for lung, breast, and pancreatic cancer.
Abraxis was incorporated in 2001 in Los Angeles. [1] It was formerly known as American Pharmaceutical Partners (APP), which as known for its injectable oncology, anti-infective and critical care. [7] Besides cancer treatments, it provided treatment for multiple sclerosis, Alzheimer's, and some cardiovascular diseases. [1]
This is a list of notable corporations headquartered in Los Angeles County, California. The table is arranged alphabetically by company. The table is arranged alphabetically by company. This is a dynamic list and may never be able to satisfy particular standards for completeness.
Dean Alexander Spanos (born May 26, 1950) is an American businessman who is the owner and chairman of the San Diego / Los Angeles Chargers of the National Football League (NFL). He is the son of Alex Spanos , who purchased majority interest in the team in 1984.
Front office. Chairman/owner/president – Dean Spanos Vice chairman – Michael Spanos; Executive vice president/COO/CFO – Jeanne Bonk; CEO/president of business operations – A. G. Spanos
Grifols, S.A. (Catalan: [ˈɡɾifuls]) is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma –based products, a field in which it is the European leader and largest worldwide, [ 3 ] [ 4 ] the company also supplies devices , instruments, and reagents for clinical testing laboratories .
Baxter International was founded in 1931 by Donald Baxter, a Los Angeles-based medical doctor, as a manufacturer and distributor of intravenous therapy solutions. [4] Seeing a need for products closer to the Midwest, the company opened a manufacturing plant in Glenview, Illinois, in 1933. [4]
In June 2019, U.S. pharmaceutical company AbbVie announced it had reached an agreement to acquire Allergan for $63 billion, [7] which would return Allergan to the U.S. for tax purposes. [8] On the announcement of the transaction, Abbvie disclosed that its 2019 net effective tax rate was 9%, but that post the acquisition, the Group's effective ...